OBJECTIVE: Bone morphogenetic protein receptor 2 (BMPR2) and hypoxia-inducible factor 1-α (HIF1-α) existed abnormal expression in several types of cancer. However, their expressions and related roles in osteosarcoma are largely unknown. METHODS: To investigate the clinical significance of BMPR2 and HIF1-α in osteosarcoma, we analyzed their expression levels in 103 osteosarcoma specimens by immunochemistry. Meanwhile, we conducted a follow-up to examine the metastatic behavior and overall survival (OS) of osteosarcoma patients. RESULTS: Among 103 tissues, 61 cases had BMPR2-positive expression and 57 cases had HIF1-α positive expression. A significant correlation was noticed between BMPR2 and HIF1-α expression in osteosarcoma specimens (P=0.035). Receiver-operating characteristic (ROC) curves were calculated to investigate the predictive value of the two markers in tumor metastasis. By means of univariate and multivariate analysis, BMPR2 and HIF1-α expression, as well as higher tumor grade, were identified as significant risk factors for OS in patients with osteosarcoma. Kaplan-Meier survival analysis revealed that the patients with BMPR2 and HIF1-α positive expression had worse OS compared with patients with BMPR2-negative or HIF1-α-negative staining. CONCLUSIONS: It can be concluded that BMPR2 and HIF1-α expression is highly correlated with metastatic behavior in patients with osteosarcoma and can serve as predictive markers for metastasis and OS of these patients.
OBJECTIVE: Bone morphogenetic protein receptor 2 (BMPR2) and hypoxia-inducible factor 1-α (HIF1-α) existed abnormal expression in several types of cancer. However, their expressions and related roles in osteosarcoma are largely unknown. METHODS: To investigate the clinical significance of BMPR2 and HIF1-α in osteosarcoma, we analyzed their expression levels in 103 osteosarcoma specimens by immunochemistry. Meanwhile, we conducted a follow-up to examine the metastatic behavior and overall survival (OS) of osteosarcoma patients. RESULTS: Among 103 tissues, 61 cases had BMPR2-positive expression and 57 cases had HIF1-α positive expression. A significant correlation was noticed between BMPR2 and HIF1-α expression in osteosarcoma specimens (P=0.035). Receiver-operating characteristic (ROC) curves were calculated to investigate the predictive value of the two markers in tumor metastasis. By means of univariate and multivariate analysis, BMPR2 and HIF1-α expression, as well as higher tumor grade, were identified as significant risk factors for OS in patients with osteosarcoma. Kaplan-Meier survival analysis revealed that the patients with BMPR2 and HIF1-α positive expression had worse OS compared with patients with BMPR2-negative or HIF1-α-negative staining. CONCLUSIONS: It can be concluded that BMPR2 and HIF1-α expression is highly correlated with metastatic behavior in patients with osteosarcoma and can serve as predictive markers for metastasis and OS of these patients.
Authors: Amal M El-Naggar; Chansey J Veinotte; Hongwei Cheng; Thomas G P Grunewald; Gian Luca Negri; Syam Prakash Somasekharan; Dale P Corkery; Franck Tirode; Joan Mathers; Debjit Khan; Alastair H Kyle; Jennifer H Baker; Nancy E LePard; Steven McKinney; Shamil Hajee; Momir Bosiljcic; Gabriel Leprivier; Cristina E Tognon; Andrew I Minchinton; Kevin L Bennewith; Olivier Delattre; Yuzhuo Wang; Graham Dellaire; Jason N Berman; Poul H Sorensen Journal: Cancer Cell Date: 2015-05-11 Impact factor: 31.743
Authors: Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos Journal: J Cancer Res Clin Oncol Date: 2016-04-04 Impact factor: 4.553
Authors: Gillian J Hutchison; Helen R Valentine; Juliette A Loncaster; Susan E Davidson; Robert D Hunter; Stephen A Roberts; Adrian L Harris; Ian J Stratford; Patricia M Price; Catharine M L West Journal: Clin Cancer Res Date: 2004-12-15 Impact factor: 12.531
Authors: Jie Zang; Dongqing Zuo; Kristen L Shogren; Carl T Gustafson; Zifei Zhou; Michael A Thompson; Ruiwei Guo; Y S Prakash; Lichun Lu; Wei Guo; Avudaiappan Maran; Michael J Yaszemski Journal: Chin J Cancer Res Date: 2019-02 Impact factor: 5.087